Document Classification

Section Type: RESULTS

Text: The primary outcome, the placebo-corrected mean ratio of the UACR at day 90 relative to baseline, was reduced in the finerenone 7. 5 -, 10 -, 15 -, and 20-mg/d groups (for 7. 5 mg/d, 0. 79 [90 % CI, 0. 68-0. 91 ; P =. 004] ; for 10 mg/d, 0. 76 [90 % CI, 0. 65-0. 88 ; P =. 001] ; for 15 mg/d, 0. 67 [90 % CI, 0. 58-0. 77 ; P <. 001] ; for 20 mg/d, 0. 62 [90 % CI, 0. 54-0. 72 ; P <. 001]).